2017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis


TUNCER T., Cay F. H., ALTAN İNCEOĞLU L., GÜRER G., KAÇAR C., ÖZÇAKIR Ş., ...Daha Fazla

RHEUMATOLOGY INTERNATIONAL, cilt.38, sa.8, ss.1315-1331, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 8
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s00296-018-4044-y
  • Dergi Adı: RHEUMATOLOGY INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1315-1331
  • Anahtar Kelimeler: Knee osteoarthritis, Treatment, Evidence-based recommendations, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, DOUBLE-BLIND, TASK-FORCE, THERAPEUTIC ULTRASOUND, CLINICAL EFFECTIVENESS, EULAR RECOMMENDATIONS, CHONDROITIN SULFATE, STANDING-COMMITTEE, NEUROPATHIC PAIN, EFFICACY
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

In a Turkish League Against Rheumatism (TLAR) project, evidence-based recommendations for the management of knee osteoarthritis (OA) was developed for the first time in our country in 2012 (TLAR-2012). In accordance with developing medical knowledge and scientific evidence, recommendations were updated. The committee was composed of 22 physical medicine and rehabilitation specialists (4 have rheumatology subspeciality also) and an orthopaedic surgeon. Systematic literature search were applied on Pubmed, Embase, Cochrane and Turkish Medical Index for the dates between January the 1st 2012 and January the 29th of 2015. The articles were assessed for quality and classified according to hierarchy for the level of evidence, and the selected ones sent to committee members electronically. They were asked to develop new recommendations. In the meeting in 2015, the format of the recommendations was decided to be patient-based and considering the grade and the severity of the disease. By the discussion of the each item under the light of new evidences, the final recommendations were developed. Each item was voted electronically on a 10-cm visual analogue scale (VAS) and the strength of recommendation (SoR) was calculated. In the light of evidences, totally 11 titles of recommendations were developed; the first 7 were applicable to each patient in every stages of the disease, remaining were for defined specific clinical situations. The mean SoR value of the recommendations was between 7.44 and 9.93. TLAR-2012 recommendations were updated in a new format. We think that, present recommendations will be beneficial for the physicians who manage, as well as the patients who suffer from the disease.